Literature DB >> 31173360

FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders.

Eric Jauniaux1, Diogo Ayres-de-Campos2, Jens Langhoff-Roos3, Karin A Fox4, Sally Collins5,6.   

Abstract

Placenta accreta spectrum is impacting maternal health outcomes globally and its prevalence is likely to increase. Maternal outcomes depend on identification of the condition before or during delivery and, in particular, on the differential diagnosis between its adherent and invasive forms. However, accurate estimation of its prevalence and outcome is currently problematic because of the varying use of clinical criteria to define it at birth and the lack of detailed pathologic examination in most series. Adherence to this new International Federation of Gynecology and Obstetrics (FIGO) classification should improve future systematic reviews and meta-analyses and provide more accurate epidemiologic data which are essential to develop new management strategies.
© 2019 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Accreta; Classification; Increta; Percreta; Placenta

Mesh:

Year:  2019        PMID: 31173360     DOI: 10.1002/ijgo.12761

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  40 in total

1.  Effect of types of placenta previa on maternal and neonatal outcomes: a 10-year retrospective cohort study.

Authors:  Shilei Bi; Lizi Zhang; Zhijian Wang; Jingsi Chen; Jingman Tang; Jingjin Gong; Sushan Xie; Lin Lin; Luwen Ren; Shanshan Zeng; Lijun Huang; Shaoshuai Wang; Lili Du; Dunjin Chen
Journal:  Arch Gynecol Obstet       Date:  2021-01-02       Impact factor: 2.344

Review 2.  Placenta accreta spectrum.

Authors:  Valerie Bloomfield; Stacey Rogers; Nicholas Leyland
Journal:  CMAJ       Date:  2020-08-24       Impact factor: 8.262

3.  Placental magnetic resonance imaging Part I: the normal placenta.

Authors:  Mariana L Meyers; Brandon P Brown
Journal:  Pediatr Radiol       Date:  2020-01-23

4.  Assessment of the massive hemorrhage in placenta accreta spectrum with magnetic resonance imaging.

Authors:  Jie Zhang; Han Xu; Yinghui Xin; Chunhua Zhang; Zhiling Liu; Xue Han; Qingwei Liu; Yan Li; Zhaoqin Huang
Journal:  Exp Ther Med       Date:  2020-01-15       Impact factor: 2.447

5.  Impact of placenta previa with placenta accreta spectrum disorder on fetal growth.

Authors:  E Jauniaux; I Dimitrova; N Kenyon; M Mhallem; N A Kametas; N Zosmer; C Hubinont; K H Nicolaides; S L Collins
Journal:  Ultrasound Obstet Gynecol       Date:  2019-11       Impact factor: 7.299

Review 6.  Management of patients with suspected placenta accreta spectrum.

Authors:  S C Reale; M K Farber
Journal:  BJA Educ       Date:  2021-12-21

Review 7.  Trophoblast invasion: Lessons from abnormally invasive placenta (placenta accreta).

Authors:  Nicholas P Illsley; Sonia C DaSilva-Arnold; Stacy Zamudio; Manuel Alvarez; Abdulla Al-Khan
Journal:  Placenta       Date:  2020-01-10       Impact factor: 3.481

Review 8.  Placental magnetic resonance imaging Part II: placenta accreta spectrum.

Authors:  Brandon P Brown; Mariana L Meyers
Journal:  Pediatr Radiol       Date:  2020-01-23

Review 9.  Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel.

Authors:  Jonathan L Hecht; Rebecca Baergen; Linda M Ernst; Philip J Katzman; Suzanne M Jacques; Eric Jauniaux; T Yee Khong; Leon A Metlay; Liina Poder; Faisal Qureshi; Joseph T Rabban; Drucilla J Roberts; Scott Shainker; Debra S Heller
Journal:  Mod Pathol       Date:  2020-05-15       Impact factor: 7.842

Review 10.  Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020.

Authors:  John C Kingdom; Sebastian R Hobson; Ally Murji; Lisa Allen; Rory C Windrim; Evelyn Lockhart; Sally L Collins; Hooman Soleymani Majd; Moiad Alazzam; Feras Naaisa; Alireza A Shamshirsaz; Michael A Belfort; Karin A Fox
Journal:  Am J Obstet Gynecol       Date:  2020-01-30       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.